Assort Health

Summary active Updated Jun 28, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location San Francisco, CA
Latest Stage Series C
Total Raised $222M

Investors

Matt Humphrey Seed (2024)
Kristina Shen Series A ($26M total, Chemistry co-led) (2025)
Menlo Ventures series-c (2026)
First Round Capital series-c (2026)
Chemistry series-c (2026)
Quiet Capital series-c (2026)

Founders

Jon Wang Founder & Co-CEO
Jeffery Liu Founder & Co-CEO

About

Assort Health is an AI agents platform for the patient journey in healthcare, handling tasks from scheduling and intake to referrals, forms, document processing, medication refills, and payments 12. The company says its platform is built on 190 million specialty patient interactions and that customers see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score 1. Revenue grew 20x in the 15 months preceding the Series C 1.

Funding History

Date Round Amount Lead Co-investors
2026-06-24 Series C $120M Menlo Ventures Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, Quiet Capital 12

The Series C valued Assort Health at $1.2 billion and brought total funding to more than $222 million 12. JP Sanday, Partner at Menlo Ventures, joined the board; fellow Menlo partner Matt Murphy serves as a board observer 1.

What Investors Say

“Every so often a company comes along that fundamentally reimagines how an industry operates. Assort is that company for healthcare.”

— JP Sanday, Partner at Menlo Ventures 1

“The value of Assort’s platform compounds with every patient interaction. Each one surfaces a new edge case and a new way to improve care, and the platform gets better for the next patient, automatically.”

— Matt Murphy, Partner at Menlo Ventures 1

What Founders Say

“This market is going to consolidate in the same way every other one has. Provider groups know it, and the smart ones aren’t buying another point solution.”

— Jon Wang, Founder and Co-CEO of Assort Health 1

“Specialty care is a different discipline than most AI vendors realize, and that difficulty only compounds at large health systems.”

— Jeffery Liu, Founder and Co-CEO of Assort Health 1

Sources


  1. Assort Health blog, “Assort Health Raises $120 Million Series C to Scale Largest Deployment of AI Agents for the Patient Journey,” June 24, 2026, accessed June 28, 2026. https://www.assorthealth.com/blog/assort-health-raises-120-million-series-c-to-scale-largest-deployment-of-ai-agents-for-the-patient-journey

  2. HIT Consultant, “Assort Health Raises $120M at a $1.2B Valuation to Scale Patient Access AI Agents,” June 24, 2026, accessed June 28, 2026. https://hitconsultant.net/2026/06/24/assort-health-raises-120-million-series-c-menlo/